214 related articles for article (PubMed ID: 36007937)
1. Relationship between orthostatic blood pressure changes and intensive blood pressure management in patients with hypertension.
Pei J; Zhang H; Li Y; Yan J; Zheng K; Wang X; Zheng XL; Hu X
Heart; 2022 Dec; 109(2):111-118. PubMed ID: 36007937
[TBL] [Abstract][Full Text] [Related]
2. Orthostatic changes in systolic blood pressure among SPRINT participants at baseline.
Townsend RR; Chang TI; Cohen DL; Cushman WC; Evans GW; Glasser SP; Haley WE; Olney C; Oparil S; Del Pinto R; Pisoni R; Taylor AA; Umanath K; Wright JT; Yeboah J;
J Am Soc Hypertens; 2016 Nov; 10(11):847-856. PubMed ID: 27665708
[TBL] [Abstract][Full Text] [Related]
3. Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis.
Juraschek SP; Hu JR; Cluett JL; Ishak AM; Mita C; Lipsitz LA; Appel LJ; Beckett NS; Coleman RL; Cushman WC; Davis BR; Grandits G; Holman RR; Miller ER; Peters R; Staessen JA; Taylor AA; Thijs L; Wright JT; Mukamal KJ
JAMA; 2023 Oct; 330(15):1459-1471. PubMed ID: 37847274
[TBL] [Abstract][Full Text] [Related]
4. Orthostatic hypotension, orthostatic hypertension, and ambulatory blood pressure in patients with chronic kidney disease in CRIC.
Ghazi L; Cohen JB; Townsend RR; Drawz PE; Rahman M; Pradhan N; Cohen DL; Weir MR; Rincon-Choles H; Juraschek SP
J Hypertens; 2024 Feb; 42(2):329-336. PubMed ID: 37889527
[TBL] [Abstract][Full Text] [Related]
5. Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT.
Juraschek SP; Taylor AA; Wright JT; Evans GW; Miller ER; Plante TB; Cushman WC; Gure TR; Haley WE; Moinuddin I; Nord J; Oparil S; Pedley C; Roumie CL; Whittle J; Wiggers A; Finucane C; Anne Kenny R; Appel LJ; Townsend RR;
Hypertension; 2020 Mar; 75(3):660-667. PubMed ID: 31983312
[TBL] [Abstract][Full Text] [Related]
6. Risk of Chronic Kidney Disease Associated With Orthostatic Hypotensive Stress: A Community-Based Korean Study.
Ko HL; Min HK; Lee SW
Am J Hypertens; 2022 Jul; 35(7):656-663. PubMed ID: 35353880
[TBL] [Abstract][Full Text] [Related]
7. Hypertension Treatment Effects on Orthostatic Hypotension and Its Relationship With Cardiovascular Disease.
Juraschek SP; Appel LJ; Miller ER; Mukamal KJ; Lipsitz LA
Hypertension; 2018 Oct; 72(4):986-993. PubMed ID: 30354704
[TBL] [Abstract][Full Text] [Related]
8. Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials.
Oikonomou EK; Spatz ES; Suchard MA; Khera R
Lancet Digit Health; 2022 Nov; 4(11):e796-e805. PubMed ID: 36307193
[TBL] [Abstract][Full Text] [Related]
9. Effect of enalapril and nifedipine on orthostatic hypotension in older hypertensive patients.
Slavachevsky I; Rachmani R; Levi Z; Brosh D; Lidar M; Ravid M
J Am Geriatr Soc; 2000 Jul; 48(7):807-10. PubMed ID: 10894321
[TBL] [Abstract][Full Text] [Related]
10. The Association of Orthostatic Hypotension With Ambulatory Blood Pressure Phenotypes in SPRINT.
Ghazi L; Drawz PE; Pajewski NM; Juraschek SP
Am J Hypertens; 2021 May; 34(5):511-520. PubMed ID: 33186448
[TBL] [Abstract][Full Text] [Related]
11. Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance.
Fleg JL; Evans GW; Margolis KL; Barzilay J; Basile JN; Bigger JT; Cutler JA; Grimm R; Pedley C; Peterson K; Pop-Busui R; Sperl-Hillen J; Cushman WC
Hypertension; 2016 Oct; 68(4):888-95. PubMed ID: 27504006
[TBL] [Abstract][Full Text] [Related]
12. Association Between Baseline Diastolic Blood Pressure and the Efficacy of Intensive vs Standard Blood Pressure-Lowering Therapy.
Foy AJ; Filippone EJ; Schaefer E; Nudy M; Ruzieh M; Dyer AM; Chinchilli VM; Naccarelli GV
JAMA Netw Open; 2021 Oct; 4(10):e2128980. PubMed ID: 34668944
[TBL] [Abstract][Full Text] [Related]
13. Orthostatic hypotension and orthostatic hypertension are both associated with lower cognitive function: The S.AGES cohort.
Strumia M; Vidal JS; Cestac P; Sallerin B; Hanon O; Rouch L;
J Am Geriatr Soc; 2023 Dec; 71(12):3721-3730. PubMed ID: 37655948
[TBL] [Abstract][Full Text] [Related]
14. Intensive Blood Pressure Lowering in Individuals With Low Diastolic Blood Pressure and Elevated Troponin Levels in SPRINT.
Smith C; Berry JD; Scherzer R; de Lemos JA; Nambi V; Ballantyne CM; Kravitz RL; Killeen AA; Ix JH; Shlipak MG; Ascher SB
J Am Heart Assoc; 2024 Mar; 13(6):e032493. PubMed ID: 38497469
[TBL] [Abstract][Full Text] [Related]
15. The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes.
Ilkun OL; Greene T; Cheung AK; Whelton PK; Wei G; Boucher RE; Ambrosius W; Chertow GM; Beddhu S
Diabetes Care; 2020 Aug; 43(8):1878-1884. PubMed ID: 32366577
[TBL] [Abstract][Full Text] [Related]
16. Association of Orthostatic Hypotension Timing With Clinical Events in Adults With Diabetes and Hypertension: Results From the ACCORD Trial.
Juraschek SP; Lipsitz LA; Beach JL; Mukamal KJ
Am J Hypertens; 2019 Jun; 32(7):684-694. PubMed ID: 30715100
[TBL] [Abstract][Full Text] [Related]
17. Postural blood pressure changes and associated factors in long-term Type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Hirai FE; Moss SE; Klein BE; Klein R
J Diabetes Complications; 2009; 23(2):83-8. PubMed ID: 18413171
[TBL] [Abstract][Full Text] [Related]
18. Orthostatic Hypertension and Intensive Blood Pressure Control; Post-Hoc Analyses of SPRINT.
Rahman M; Pradhan N; Chen Z; Kanthety R; Townsend RR; Tatsuoka C; Wright JT
Hypertension; 2021 Jan; 77(1):49-58. PubMed ID: 33161773
[TBL] [Abstract][Full Text] [Related]
19. Single Agent Antihypertensive Therapy and Orthostatic Blood Pressure Behaviour in Older Adults Using Beat-to-Beat Measurements: The Irish Longitudinal Study on Ageing.
Canney M; O'Connell MD; Murphy CM; O'Leary N; Little MA; O'Seaghdha CM; Kenny RA
PLoS One; 2016; 11(1):e0146156. PubMed ID: 26730962
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure variability predicts adverse events and cardiovascular outcomes in SPRINT.
Mezue K; Goyal A; Pressman GS; Matthew R; Horrow JC; Rangaswami J
J Clin Hypertens (Greenwich); 2018 Sep; 20(9):1247-1252. PubMed ID: 29984884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
